CDK5 and Huntington disease: Inhibition of Cdk5 activity in the nucleus accumbens attenuated the depressive-like behaviors of HD mice through modulating dendritic spine plasticity mediated by dopamine- and cAMP-regulated phosphoprotein 32 (DARPP32)/β-adducin signaling pathway (Brito et al., 2019).